DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	115,470	147,920	131,049	156,349	169,609	232,556
Market Cap Growth	-20.19%	12.87%	-16.18%	-7.82%	-27.07%	-3.33%
Enterprise Value	202,813	232,426	172,921	172,036	175,056	221,869
Last Close Price	4270.00	5470.00	4694.12	5398.48	5731.92	7541.16
PE Ratio	2.41	2.94	64.38	13.24	25.64	24.94
PS Ratio	0.48	0.61	0.53	0.73	0.87	1.50
PB Ratio	0.78	0.97	1.24	1.42	1.66	2.32
P/TBV Ratio	0.83	1.01	1.31	1.57	1.82	2.40
P/FCF Ratio	-	-	-	-	14.32	17.05
P/OCF Ratio	19.52	-	7.56	43.61	10.08	12.99
EV/Sales Ratio	0.84	0.96	0.69	0.80	0.90	1.43
EV/EBITDA Ratio	11.65	12.79	8.66	8.33	7.79	16.82
EV/EBIT Ratio	23.25	25.13	13.63	11.77	10.40	27.26
EV/FCF Ratio	-20.76	-	-	-	14.78	16.27
Debt / Equity Ratio	0.86	0.85	0.82	0.40	0.34	0.24
Debt / EBITDA Ratio	7.36	7.09	4.34	2.12	1.53	1.84
Debt / FCF Ratio	-	-	-	-	2.90	1.78
Net Debt / Equity Ratio	0.58	0.62	0.48	0.19	-0.01	-0.08
Net Debt / EBITDA Ratio	4.99	5.15	2.52	1.01	-0.04	-0.59
Net Debt / FCF Ratio	-8.89	-4.27	-11.14	-2.04	-0.07	-0.57
Asset Turnover	0.82	0.84	1.15	1.19	1.19	1.04
Inventory Turnover	2.09	2.05	2.20	2.26	2.74	2.52
Quick Ratio	0.44	0.40	0.50	0.61	0.83	0.97
Current Ratio	0.77	0.92	0.93	1.21	1.32	1.48
Return on Equity (ROE)	40.16%	38.95%	1.84%	11.11%	6.54%	9.58%
Return on Assets (ROA)	1.84%	1.99%	3.65%	5.03%	6.44%	3.40%
Return on Invested Capital (ROIC)	2.95%	3.76%	4.61%	10.07%	14.53%	7.40%
Return on Capital Employed (ROCE)	4.50%	4.60%	9.90%	12.40%	15.90%	7.80%
Earnings Yield	43.63%	33.99%	1.55%	7.56%	3.90%	4.01%
FCF Yield	-8.46%	-14.84%	-3.45%	-6.56%	6.98%	5.86%
Payout Ratio	6.44%	6.46%	162.74%	25.72%	42.39%	10.11%
Buyback Yield / Dilution	-5.42%	-3.59%	1.74%	0.48%	1.78%	0.12%